EGFR (ErbB1 or HER1) Antibody - FFPE Validated

About the Target

Bring EGFR (HER1) into view to examine changes across conditions. EGFR is a signaling node often evaluated by abundance, localization, and modification-dependent states. Look for shifts in distribution that track with phenotype changes.

In some datasets and protocols, it is referenced by the gene symbol HER1.

Research Context

Parallel measurement of upstream inputs and downstream readouts can sharpen interpretation of pathway behavior. Pair measurements with orthogonal readouts when interpretation is sensitive to context. In oncology research models, expression shifts can accompany changes in adhesion, signaling, or differentiation state.

Consider these angles when interpreting target-level changes:

• localization shifts between cytoplasm, membrane, and nucleus
• condition-to-condition comparisons with matched controls
• interaction patterns within multi-protein complexes
• time-resolved changes following stimulation or inhibition

Variant Considerations

Because fixation can mask epitopes, fixed-section oriented formats aim to maintain recognition after standard deparaffinization and retrieval steps. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

When interpreting EGFR, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

For challenging targets, pairing EGFR measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

With a clear focus on EGFR (HER1), this fixed-section option fits streamlined studies and fast iteration.